New Delhi: Torrent Pharmaceuticals has received the green light from the Competition Commission of India (CCI) for its proposed Rs 19,500 crore acquisition of J.B. Chemicals & Pharmaceuticals, but with voluntary modifications to address potential concerns over market dominance.

The proposed acquisition, which relates to acquisition of shareholding by Torrent in J.B. Chemicals, followed by an amalgamation of the two companies, had earlier raised alarm bells at the CCI.

In July, Torrent sought CCI nod to acquire a majority stake in J.B. Chemicals.

Read also: Torrent Pharma seeks CCI clearance to acquire majority stake in JB Pharma in Rs 19500 crore deal

However, in response to this in mid-October, the antitrust watchdog warned that the deal could create a dominant position in critic

See Full Page